Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
Open Access
- 20 April 2023
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 184, 109674
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Practical recommendations for reportingFine‐Gray model analyses for competing risk dataStatistics in Medicine, 2017
- Response Assessment in Neuro-Oncology Clinical TrialsJournal of Clinical Oncology, 2017
- Molecular and histologic characteristics of pseudoprogression in diffuse gliomasJournal of Neuro-Oncology, 2016
- Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Imaging of oligodendrogliomaBritish Journal of Radiology, 2016
- Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transferPhysics in Medicine & Biology, 2014
- Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802Journal of Clinical Oncology, 2012
- Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomideCancer, 2008
- Immediate post-radiotherapy changes in malignant glioma can mimic tumor progressionNeurology, 2004
- Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after TreatmentRadiology, 2000